Aelis Farma SA AELIS.PA
€1.00 €0.00 (0.20%) 1D
Last Updated: Jun 23, 12:00 AM·XPAR
Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
AELIS.PA Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: July 25, 2025
Report Source: 2024 Annual Report
Aelis Farma SA. Stock Analysis AELIS.PA
France Health Care Nano Cap Report: Aelis Farma SA is a biopharmaceutical company. The firm provides two products in clinical development, including AEF0117 for cannabis-related disorders (severe dependence, acute psychosis, and acute toxicity), and AEF0217 for cognitive deficits (disorders related to Down syndrome). The company offers viable treatments for certain pathological conditions linked to hyperactivity of the CB1 receptor, the main receptor of the endocannabinoid system. The company provides advanced drug AEF0117, to combat the harmful effects of cannabis and in particular Cannabis Use Disorders (CUD) which is the current definition of cannabis addiction in the diagnostic manual reference DSM-5. The firm operates a Research and Development (R&D) platform, which enables the Company to discover drug candidates that act as specific modulators of target receptor signaling.
Read More Aelis Farma SA (AELIS.PA) Chart
Key Statistics of Aelis Farma SA (AELIS.PA)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
€1.00Volume
25.47KP/E Ratio (TTM)
-52 Week Range
Market Cap
16.45MAvg. Volume
29.09KDividend Yield
-Financial Metrics & Statements of Aelis Farma SA (AELIS.PA)
FAQ's for Aelis Farma SA (AELIS.PA)
- According to Musaffa’s Shariah screening methodology, Aelis Farma SA (AELIS.PA) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Aelis Farma SA using these criteria to determine its compliance status.
- Muslim investors may consider investing in Aelis Farma SA if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Aelis Farma SA by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Aelis Farma SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Aelis Farma SA on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.